AINewsnow

Isomorphic Labs raises $5B Series C to accelerate AI drug discovery

This story is from 2026-11-17. It is preserved in the archive; the latest stories are on the live feed.

Isomorphic Labs, Alphabet's AI drug-discovery company led by Demis Hassabis, raised a $5B Series C co-led by Greenoaks and Sequoia, following a $2.1B round in May and $600M in March 2025.

Read the full story at Techmeme ↗

Timeline · 4 reports

  1. 2026-11-17 12:53 · Unite.AI
    Isomorphic Labs Raises $5B Series C to Advance AI Drug Design
  2. 2026-11-17 12:35 · The Next Web
    Isomorphic Labs raises $5bn from Sequoia and Greenoaks for AI drug design
  3. 2026-11-17 12:11 · Techmeme
    Alphabet's Isomorphic Labs raised a $5B Series C led by Sequoia and Greenoaks, after raising $2.1B in May and $600M in March 2025, to accelerate clinical trials (Bloomberg)
  4. 2026-11-17 12:10 · r/singularity
    Isomorphic Labs just raised $5B for AI drug discovery. When will its first drug reach human trials?

More stories

  1. Alphabet's Isomorphic Labs raises $5B Series C led by Sequoia and Greenoaks — Bloomberg AI
  2. Alphabet-backed AI drug developer Isomorphic Labs raises $5 billion Series C — Reuters AI
  3. Google launches Gemini 4 Neon mid-tier model and opens Genie 4 to Gemini API developers — Google DeepMind YouTube
  4. Google books Blue Origin's New Glenn for 2029 launch of AI server satellites — Google: The Keyword
  5. ChatGPT, Claude, Gemini and Grok helped plan terror attacks in US government test — The Independent Tech
  6. Google Builds 'Mirror Dimension' Synthetic Internet to Test Chrome AI Browsing Agents — Wired AI
  7. Google adds YouTube Premium Family to its AI Ultra subscription tier — The Verge AI
  8. Anthropic Appears Among Market-Moving Names Across Recent Trading Sessions — Barron's

Read the Daily Brief: the day's most important AI stories →